| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 45.46B | 44.08B | 44.14B | 41.32B | 40.40B | 34.80B |
| Gross Profit | 26.39B | 24.78B | 24.64B | 23.51B | 24.14B | 21.22B |
| EBITDA | 17.78B | 17.12B | 16.71B | 15.70B | 16.83B | 15.76B |
| Net Income | 11.60B | 10.96B | 10.73B | 9.84B | 11.44B | 10.68B |
Balance Sheet | ||||||
| Total Assets | 53.48B | 61.79B | 58.64B | 65.95B | 59.16B | 54.18B |
| Cash, Cash Equivalents and Short-Term Investments | 30.08B | 39.21B | 37.44B | 45.58B | 47.30B | 42.86B |
| Total Debt | 4.70B | 5.40B | 6.30B | 0.00 | 0.00 | 500.00M |
| Total Liabilities | 9.30B | 14.20B | 14.67B | 11.23B | 8.13B | 9.49B |
| Stockholders Equity | 43.77B | 47.17B | 43.91B | 54.45B | 50.76B | 44.48B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 13.05B | 10.42B | 7.99B | 10.85B | 11.32B |
| Operating Cash Flow | 0.00 | 13.12B | 10.55B | 8.30B | 11.10B | 11.46B |
| Investing Cash Flow | 0.00 | 11.98B | -18.22B | -4.15B | 270.48M | 22.49B |
| Financing Cash Flow | 0.00 | -8.75B | -15.23B | -6.09B | -5.94B | -3.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥82.28B | 23.14 | ― | 4.32% | 11.99% | -4.74% | |
80 Outperform | ¥196.91B | 6.74 | ― | 4.01% | -2.39% | -4.54% | |
76 Outperform | ¥216.99B | 12.40 | 26.65% | 4.00% | 10.37% | 18.68% | |
69 Neutral | ¥3.74T | 10.42 | 10.23% | 3.93% | -2.45% | 35.60% | |
69 Neutral | ¥102.74B | 15.70 | ― | 1.54% | 17.13% | 23.53% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
43 Neutral | ¥171.08B | 13.27 | 7.26% | 4.16% | 14.69% | -114.36% |